Fulcrum Therapeutics, Inc. (FULC)
3.775
-0.02
(-0.40%)
USD |
NASDAQ |
Sep 17, 16:00
3.775
0.00 (0.00%)
After-Hours: 20:00
Fulcrum Therapeutics Price : 3.775 for Sept. 17, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 16, 2026 | 3.80 | 3.815 | 3.77 | 3.79 | 1.125M |
| Sep 15, 2026 | 3.80 | 3.80 | 3.75 | 3.78 | 1.327M |
| Sep 14, 2026 | 3.82 | 3.82 | 3.775 | 3.79 | 706476.0 |
| Sep 11, 2026 | 3.85 | 3.85 | 3.78 | 3.80 | 814753.0 |
| Sep 10, 2026 | 3.82 | 3.835 | 3.79 | 3.80 | 1.328M |
| Sep 09, 2026 | 3.82 | 3.85 | 3.78 | 3.84 | 1.385M |
| Sep 08, 2026 | 3.80 | 3.85 | 3.795 | 3.82 | 1.110M |
| Sep 04, 2026 | 3.81 | 3.855 | 3.80 | 3.85 | 1.005M |
| Sep 03, 2026 | 3.87 | 3.89 | 3.82 | 3.84 | 1.436M |
| Sep 02, 2026 | 3.88 | 3.90 | 3.825 | 3.85 | 1.634M |
| Sep 01, 2026 | 3.85 | 3.88 | 3.82 | 3.87 | 1.682M |
| Aug 31, 2026 | 3.83 | 3.915 | 3.796 | 3.89 | 1.798M |
| Aug 28, 2026 | 3.82 | 3.87 | 3.78 | 3.85 | 1.891M |
| Aug 27, 2026 | 3.86 | 3.89 | 3.825 | 3.85 | 785024.0 |
| Aug 26, 2026 | 3.86 | 3.88 | 3.82 | 3.86 | 854863.0 |
| Aug 25, 2026 | 3.87 | 3.89 | 3.835 | 3.86 | 1.320M |
| Aug 24, 2026 | 3.835 | 3.86 | 3.78 | 3.84 | 856383.0 |
| Aug 21, 2026 | 3.85 | 3.90 | 3.78 | 3.83 | 1.513M |
| Aug 20, 2026 | 3.88 | 3.907 | 3.81 | 3.85 | 1.198M |
| Aug 19, 2026 | 3.90 | 3.94 | 3.855 | 3.91 | 2.179M |
| Aug 18, 2026 | 3.85 | 3.90 | 3.745 | 3.87 | 2.751M |
| Aug 17, 2026 | 3.81 | 3.90 | 3.751 | 3.84 | 8.440M |
| Aug 14, 2026 | 3.70 | 3.755 | 3.65 | 3.74 | 980415.0 |
| Aug 13, 2026 | 3.75 | 3.76 | 3.64 | 3.71 | 1.357M |
| Aug 12, 2026 | 3.70 | 3.74 | 3.615 | 3.72 | 901396.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Cocrystal Pharma, Inc. | 1.14 |
| CNBX Pharmaceuticals, Inc. | 0.0001 |
| GB Sciences, Inc. | 0.0002 |
| Arvinas, Inc. | 8.305 |
| Definium Therapeutics, Inc. | 38.68 |
Price Related Metrics
| Price to Book Value | 0.9269 |
| Earnings Yield | -32.14% |
| Market Cap | 287.98M |